Coronary disease & ACSMeta-analysis

Complete Percutaneous Coronary Revascularization in Acute Coronary Syndromes With Multivessel Coronary Disease

JACC Cardiovasc IntervPublished

  • Systematic review

Study context

Population
Acute coronary syndromes (ACS) patients with multivessel disease undergoing percutaneous revascularization

Pooled result

As reported in the abstract

Benefit of complete revascularization in ACS with MVD (narrative evidence summary)
  • Benefits of complete revascularization established in hemodynamically stable ACS patients with multivessel disease (MVD)
  • Evidence solid for STEMI; less robust for NSTEMI and cardiogenic shock
  • Uncertain: optimal timing of complete revascularization and best guiding strategy for intermediate stenoses

Original publication

Complete Percutaneous Coronary Revascularization in Acute Coronary Syndromes With Multivessel Coronary Disease. JACC Cardiovasc Interv. Published 9 October 2023. doi:10.1016/j.jcin.2023.07.043

Summarised from the published abstract; every number is checked against it